INMUNE BIO INC (INMB:NASDAQ)
$1.18 -0.1 (-7.8125%)
Analysed INMUNE BIO INC (INMB:NASDAQ) News Sources
INmune Bio (NASDAQ:INMB) Will Have To Spend Its Cash Wisely
01-04-2026
yahoo.com
INmune Bio, Inc. Q4 2025 Earnings Call Summary
31-03-2026
moby.co
INmune Bio Inc (INMB) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
31-03-2026
yahoo.com
INmune Bio Inc. Announces 2025 Results and Provides Business Update
30-03-2026
yahoo.com
INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.
24-03-2026
yahoo.com
INmune Bio’s MINDFuL Trial Featured at AD/PD 2026 Plenary as Successful Example of How to Approach Clinical Trials Targeting Inflammation in Early Alzheimer’s Disease
19-03-2026
yahoo.com
INmune Bio to Detail XPro1595 Registrational Strategy in Upcoming Alzheimer’s Webinar
23-02-2026
yahoo.com
INmune Bio Announces Upcoming Webinar to Present New Clinical Data on CORDStrom™ for RDEB
19-02-2026
yahoo.com
INmune Bio Announces FDA Alignment on Integrated Phase 2b/3 Registration Pathway for XPro1595 in Early Alzheimer’s Disease
12-02-2026
yahoo.com
INmune Bio submits pre-submission package for CORDStrom with MHRA
11-02-2026
yahoo.com
What is the current price of INMUNE BIO INC (INMB:NASDAQ)?
The current price of INMUNE BIO INC (INMB:NASDAQ) is $1.18.
INMUNE BIO INC (INMB:NASDAQ) absolute price change since previous trading day?
The absolute price change of INMUNE BIO INC (INMB:NASDAQ) since the previous trading day is $-0.1.
INMUNE BIO INC (INMB:NASDAQ) percentage price change since previous trading day?
The percentage price change of INMUNE BIO INC (INMB:NASDAQ) since the previous trading day is -7.8125%.
What is the most recent average sentiment score for INMUNE BIO INC (INMB:NASDAQ)?
The most recent average sentiment score for INMUNE BIO INC (INMB:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for INMUNE BIO INC (INMB:NASDAQ)?
The most recent sentiment for INMUNE BIO INC (INMB:NASDAQ) is .
SEC-8K** Filing Available For INMUNE BIO INC (INMB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.